Amid a steep 60% annual share price decline, investment firm Chicago Capital has significantly reduced its position in PROCEPT BioRobotics, a developer of robotic systems for urological surgery, signaling a portfolio risk reassessment.
A looming partial government shutdown highlights critical nuances in prediction market contracts, with Polymarket and Kalshi odds soaring as procedural delays in Congress turn betting specifics into the central story.
The Biden administration has approved a major arms sale to Israel, featuring attack helicopters and armored vehicles, amid a fragile ceasefire in Gaza and ongoing scrutiny over U.S. military support.
A key ally of Prime Minister Narendra Modi has proposed legislation to prohibit social media access for children under 16, framing the move as a response to digital addiction and the exploitation of Indian user data by foreign tech giants, amid a growing global regulatory push.
While America's coffee consumption hits multi-decade highs, Starbucks' market share is eroding. The pioneer now faces a crowded battlefield of value-focused rivals, drive-thru specialists, and international entrants, forcing a strategic rethink of its iconic 'third place' model.
In a quiet corner of an Istanbul mosque, Iraqi master calligrapher Ali Zaman has concluded a six-year spiritual and artistic journey: the creation of what is believed to be the world's largest handwritten Quran. The monumental work highlights the enduring legacy of Islamic calligraphy, an art form that flourished under Ottoman patronage and continues to find a vibrant center in modern Turkey.
Shares of staffing giant Robert Half International surged nearly 28% in a single session, propelled by a significant price target increase from Truist Securities. The rally comes despite the company reporting a sharp decline in annual profits, highlighting a stark divergence between analyst confidence and recent financial performance.
Inditex (BME:ITX) shares have taken a breather, trading flat over the past week after a robust multi-year performance. With the stock slightly below analyst targets, investors are weighing whether the current price offers value or if the growth momentum is cooling.
Alm. Brand A/S posts robust Q4 2025 results, with net income soaring to DKK 337 million and proposing a record dividend. While underlining its shareholder return strategy, the market grapples with valuation concerns and execution risks in a softening share price environment.
After a punishing 61% decline in its share price over the past year, Atlassian finds itself at a critical juncture. With the stock trading near $118, investors are grappling with whether this represents a profound disconnect from long-term potential or a justified reassessment of growth prospects in a shifting market.
Despite a sharp 22% drop in cocoa sales volume and multi-year lows in cocoa futures, Barry Callebaut's (SWX:BARN) share price has rallied strongly. Analysts are divided on whether the current valuation reflects deep value or overlooks persistent headwinds in its core commodity business.
Biotech firm Definium Therapeutics appoints seasoned commercial executive Roger Adsett to its board, signaling a strategic shift towards commercialization as key late-stage trial data approaches.
Greenlight Capital has spotlighted Core Natural Resources (CNR), the entity formed from the merger of Arch Resources and CONSOL Energy, as a key coal investment. The fund cites the company's valuation and combined asset base, even as the sector grapples with operational challenges. This endorsement brings renewed scrutiny to CNR's integration path and its strategy in a complex market.
Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...
Shares of Deckers Outdoor Corp. surged nearly 20% following a robust quarterly report and an optimistic fiscal 2026 outlook, driven by exceptional performance from its UGG and HOKA footwear brands.
Disney's iconic leader, who returned to steady the company in 2022, is reportedly preparing to exit the CEO role ahead of his contract's expiration, setting the stage for a high-stakes succession search.
Shares of Charter Communications jumped more than 7% Friday after the telecom giant reported a smaller-than-anticipated decline in internet subscribers for the fourth quarter, signaling resilience in its core business amid industry-wide pressures.
Shares of Colgate-Palmolive jumped over 6% as the consumer goods giant outlined a resilient growth plan through 2026, even after reporting a significant profit decline in a tough operating climate.
Victoria's Secret shares have surged nearly 50% in the past year, leaving investors to grapple with a critical question: Is the rally justified, or has the market gotten ahead of itself? A deep dive into the numbers reveals a complex picture where traditional valuation models clash.
After a bruising year that saw its shares tumble by a third, biotech giant CSL is back in the spotlight. We delve beyond the headline numbers, examining valuation models and market sentiment to assess if the sell-off has created a compelling entry point for long-term investors.
